160 related articles for article (PubMed ID: 32488916)
21. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J
Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252
[TBL] [Abstract][Full Text] [Related]
22. Identifying barriers and enablers to opt-out hepatitis C virus screening in provincial prisons in Quebec, Canada: A multilevel, multi-theory informed qualitative study with correctional and healthcare professional stakeholders.
Ruiz AS; Fontaine G; Patey AM; Grimshaw JM; Presseau J; Cox J; Dussault C; Kronfli N
Int J Drug Policy; 2022 Nov; 109():103837. PubMed ID: 36030569
[TBL] [Abstract][Full Text] [Related]
23. The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting.
Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C
Addiction; 2021 May; 116(5):1162-1171. PubMed ID: 33006784
[TBL] [Abstract][Full Text] [Related]
24. Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review.
Kronfli N; Linthwaite B; Kouyoumdjian F; Klein MB; Lebouché B; Sebastiani G; Cox J
Int J Drug Policy; 2018 Jul; 57():95-103. PubMed ID: 29715590
[TBL] [Abstract][Full Text] [Related]
25. "You need a designated officer" - Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting.
Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C;
Int J Drug Policy; 2022 Aug; 106():103746. PubMed ID: 35636069
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C Testing and Patient Characteristics in Washington State's Prisons Between 2012 and 2016.
Assoumou SA; Wang J; Tasillo A; Eftekhari Yazdi G; Tsui JI; Strick L; Linas BP
Am J Prev Med; 2019 Jan; 56(1):8-16. PubMed ID: 30467088
[TBL] [Abstract][Full Text] [Related]
27. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting.
Sharafi H; Poustchi H; Azimian F; Tamadoni B; Ramezani R; Gouya MM; Sheikh M; Hashemi F; Tashakorian M; Alasvand R; Alavian SM; Merat S
J Clin Virol; 2019 Apr; 113():20-23. PubMed ID: 30825832
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
29. Incidence, prevalence and risk factors for hepatitis C in Danish prisons.
Søholm J; Holm DK; Mössner B; Madsen LW; Hansen JF; Weis N; Sauer AP; Awad T; Christensen PB
PLoS One; 2019; 14(7):e0220297. PubMed ID: 31348813
[TBL] [Abstract][Full Text] [Related]
30. Routine testing for blood-borne viruses in prisons: a systematic review.
Rumble C; Pevalin DJ; O'Moore É
Eur J Public Health; 2015 Dec; 25(6):1078-88. PubMed ID: 26219884
[TBL] [Abstract][Full Text] [Related]
31. Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit.
Walker SJ; Shrestha LB; Lloyd AR; Dawson O; Sheehan Y; Sheehan J; Maduka NBC; Cabezas J; Akiyama MJ; Kronfli N;
Int J Drug Policy; 2024 Apr; 126():104386. PubMed ID: 38492433
[TBL] [Abstract][Full Text] [Related]
32. Bowel cancer screening in an English prison: a qualitative service evaluation.
Blagden S; Simpson C; Limmer M
Public Health; 2020 Mar; 180():46-50. PubMed ID: 31855618
[TBL] [Abstract][Full Text] [Related]
33. Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.
Crowley D; Murtagh R; Cullen W; Keevans M; Laird E; McHugh T; McKiernan S; Miggin SJ; O'Connor E; O'Reilly D; Betts-Symonds G; Tobin C; Van Hout MC; Lambert JS
Harm Reduct J; 2019 Jul; 16(1):42. PubMed ID: 31277665
[TBL] [Abstract][Full Text] [Related]
34. Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.
Bretaña NA; Gray RR; Cunningham EB; Betz-Stablein B; Ribeiro R; Graw F; Luciani F; Lloyd AR
Addiction; 2020 May; 115(5):901-913. PubMed ID: 31633853
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus screening and treatment in Irish prisons from nurse managers' perspectives - a qualitative exploration.
Crowley D; Van Hout MC; Murphy C; Kelly E; Lambert JS; Cullen W
BMC Nurs; 2019; 18():23. PubMed ID: 31210751
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of an e-learning package to improve understanding of blood-borne viruses amongst prison staff in Wales, UK.
Ellen Perrett S; Erricker M; Lyons M
Int J Prison Health; 2014; 10(1):47-54. PubMed ID: 25763984
[TBL] [Abstract][Full Text] [Related]
37. Performance of Risk-Based and Birth-Cohort Strategies for Identifying Hepatitis C Virus Infection Among People Entering Prison, Wisconsin, 2014.
Stockman LJ; Greer J; Holzmacher R; Dittmann B; Hoftiezer SA; Alsum LE; Prieve A; Westergaard RP; Guilfoyle SM; Vergeront JM
Public Health Rep; 2016; 131(4):544-51. PubMed ID: 27453598
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey.
Wali A; Khan D; Safdar N; Shawani Z; Fatima R; Yaqoob A; Qadir A; Ahmed S; Rashid H; Ahmed B; Khan S
BMC Public Health; 2019 Dec; 19(1):1631. PubMed ID: 31801496
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison.
Okafor IM; Ugwu SO; Okoroiwu HU
BMC Gastroenterol; 2020 Oct; 20(1):360. PubMed ID: 33126856
[TBL] [Abstract][Full Text] [Related]
40. Competing priorities and second chances - A qualitative exploration of prisoners' journeys through the Hepatitis C continuum of care.
Crowley D; Cullen W; Lambert JS; Van Hout MC
PLoS One; 2019; 14(9):e0222186. PubMed ID: 31509571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
